BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21213151)

  • 21. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium.
    Duara R; Barker W; Loewenstein D; Bain L
    Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease therapeutics: new approaches to an ageing problem.
    Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
    IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic approaches to Alzheimer's disease.
    Klafki HW; Staufenbiel M; Kornhuber J; Wiltfang J
    Brain; 2006 Nov; 129(Pt 11):2840-55. PubMed ID: 17018549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and future therapy in Alzheimer's disease.
    van Marum RJ
    Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of new drugs for Alzheimer's disease].
    Tabira T
    Brain Nerve; 2010 Jul; 62(7):787-96. PubMed ID: 20675883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease-modifying therapies in Alzheimer's disease.
    Salloway S; Mintzer J; Weiner MF; Cummings JL
    Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease: a general introduction and pathomechanism.
    Finder VH
    J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natural progression of Alzheimer's disease (AD): a perspective on possible therapies for advanced AD].
    Yanagisawa K
    Rinsho Shinkeigaku; 2004 Nov; 44(11):921-3. PubMed ID: 15651332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
    Nawrot B
    Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current perspectives on pharmacotherapy of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
    Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
    Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
    Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
    Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When will Alzheimer's disease be cured? A pharmaceutical perspective.
    Townsend M
    J Alzheimers Dis; 2011; 24 Suppl 2():43-52. PubMed ID: 21368375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment and recent clinical research in Alzheimer's disease.
    Neugroschl J; Sano M
    Mt Sinai J Med; 2010; 77(1):3-16. PubMed ID: 20101716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating metals as a therapeutic strategy for Alzheimer's disease.
    Hung LW; Barnham KJ
    Future Med Chem; 2012 May; 4(8):955-69. PubMed ID: 22650238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging amyloid and tau targeting treatments for Alzheimer's disease.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):697-711. PubMed ID: 28490214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.